KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

Treatment Landscape of Nonmetastatic Castration-Resistant Prostate Cancer: A Window of Opportunity.

Fernando López-Campos, Antonio Conde-Moreno, Marta Barrado Los Arcos, Antonio Gómez-Caamaño, Raquel García-Gómez, Asunción Hervás Morón

J Pers Med 11(11) 1190

PMID34834544
PMCIDPMC8619952
DOI10.3390/jpm11111190
发表日期2021-11-27
摘要

摘要

The treatment for nonmetastatic castration-resistant prostate cancer (nmCRPC) is a highly unmet medical need. The classic treatment approach for these patients-androgen deprivation therapy (ADT) alone-until metastatic progression is now considered suboptimal. Several randomized phase III clinical trials have demonstrated significant clinical benefits-including significantly better overall survival (OS)-for treatments that combine ADT with apalutamide, enzalutamide, and darolutamide. As a result, these approaches are now included in treatment guidelines and are considered a standard of care. In the present article, we discuss the changing landscape of the management of patients with nmCRPC.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。